Pharma-Bio Serv Inc
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and pr… Read more
Market Cap & Net Worth: Pharma-Bio Serv Inc (PBSV)
Pharma-Bio Serv Inc (OTCQB:PBSV) has a market capitalization of $10.99 Million ($10.99 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #32065 globally and #10532 in its home market, demonstrating a 14.29% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharma-Bio Serv Inc's stock price $0.48 by its total outstanding shares 22904492 (22.90 Million).
Pharma-Bio Serv Inc Market Cap History: 2015 to 2025
Pharma-Bio Serv Inc's market capitalization history from 2015 to 2025. Data shows change from $13.47 Million to $10.99 Million (-1.26% CAGR).
Pharma-Bio Serv Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharma-Bio Serv Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.22x
Pharma-Bio Serv Inc's market cap is 1.22 times its annual revenue
1.54x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $13.34 Million | $19.54 Million | -$256.57K | 0.68x | N/A |
| 2017 | $7.01 Million | $15.58 Million | -$1.41 Million | 0.45x | N/A |
| 2018 | $14.57 Million | $17.80 Million | $1.28 Million | 0.82x | 11.38x |
| 2019 | $13.86 Million | $19.51 Million | $2.09 Million | 0.71x | 6.64x |
| 2020 | $23.10 Million | $21.56 Million | $2.05 Million | 1.07x | 11.26x |
| 2021 | $18.78 Million | $20.12 Million | -$2.09 Million | 0.93x | N/A |
| 2022 | $15.69 Million | $19.40 Million | $1.01 Million | 0.81x | 15.59x |
| 2023 | $22.32 Million | $16.98 Million | $1.31 Million | 1.31x | 17.03x |
| 2024 | $11.91 Million | $9.51 Million | -$777.62K | 1.25x | N/A |
| 2025 | $10.99 Million | $9.00 Million | -$100.46K | 1.22x | N/A |
Competitor Companies of PBSV by Market Capitalization
Companies near Pharma-Bio Serv Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Pharma-Bio Serv Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Pharma-Bio Serv Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Pharma-Bio Serv Inc's market cap moved from $13.47 Million to $ 10.99 Million, with a yearly change of -1.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $10.99 Million | -7.69% |
| 2024 | $11.91 Million | -46.63% |
| 2023 | $22.32 Million | +42.19% |
| 2022 | $15.69 Million | -16.42% |
| 2021 | $18.78 Million | -18.72% |
| 2020 | $23.10 Million | +66.66% |
| 2019 | $13.86 Million | -4.84% |
| 2018 | $14.57 Million | +107.91% |
| 2017 | $7.01 Million | -47.48% |
| 2016 | $13.34 Million | -1.00% |
| 2015 | $13.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pharma-Bio Serv Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.99 Million USD |
| MoneyControl | $10.99 Million USD |
| MarketWatch | $10.99 Million USD |
| marketcap.company | $10.99 Million USD |
| Reuters | $10.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.